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2212-0661/© 2016 Published by Elsevier B.V. This is an opa b s t r a c ta r t i c l e i n f oThe differences between countries in national income, growth, human development and many other factors are
used to classify countries into developed and developing countries. There are several classiﬁcation systems that
use different sets of measures and criteria. Themost common classiﬁcations are the United Nations (UN) and the
World Bank (WB) systems. The UN classiﬁcation system uses the UNHuman Development Index (HDI), an indi-
cator that uses statistic of life expectancy, education, and income per capita for countries' classiﬁcation.While the
WB system uses gross national income (GNI) per capita that is calculated using the World Bank Atlas method.
According to the UN and WB classiﬁcation systems, there are 151 and 134 developing countries, respectively,
with 89% overlap between the two systems. Developing countries have limited human development, and limited
expenditure in education and research, among several other limitations. The biggest challenge facing genomic re-
searchers and clinicians is limited resources. As a result, genomic tools, speciﬁcally genome sequencing technol-
ogies, which are rapidly becoming indispensable, are not widely available. In this report, we explore the current
status of sequencing technologies in developing countries, describe the associated challenges and emphasize po-
tential solutions.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Countries are generally classiﬁed into developed and developing
countries using several classifying systems. There are many factors
used to rank/classify countries such as the national income, human de-
velopment and growth rate. For instance, the United Nations (UN) uses
the UNHuman Development Index (HDI) that is a summarymeasure of
the average achievements in key aspects of human development, and
the World Bank (WB) uses gross national income (GNI) per capita for
this form of classiﬁcation (United Nations, 2014; World Bank, 2016).
These classiﬁcations are used to assess how a country is progressing,
aswell aswhat needs remain unmet, such as funding or long term strat-
egies. Health, education, and scientiﬁc research are among the ﬁelds
that need attention in the developing countries since they are tightly
connected with the human development and the country's national in-
come. Genomics and other ‘omics’ disciplines have proven to be valu-
able tools to be effectively applied to many ﬁelds including food, drug,
and health development. The ability to become proﬁcient and deployology, Faculty of Agriculture,
of Applied Biology, College of
h, United Arab Emirates.
arjah.ac.ae (K.A. Mosa).
en access article under the CC BY-NC‘omics’ offers opportunities for developing nations to advance knowl-
edge as well as improve health risk identiﬁcation, diagnoses, treatment
and prevention.
Genome sequencing represents a landmark in the way scientists
study the genetic information of living organisms. In the 1970s, the
ﬁrst generation of genome sequencing methods was introduced and
was industrialized and widely distributed in the following years
(Sanger et al., 1977). This generation of genome sequencing methods
had high accuracy and a relatively long read-length. However, it was
also expensive and slow,which limited the utilization of the genome se-
quencing technologies to only institutions that could afford the high
costs of establishing and running genome sequencing facilities. For in-
stance, the genome sequencing component of the Human Genome Pro-
ject (HGP) cost 100 million U.S. dollars and required about 13 years to
complete (El-Metwally et al., 2014a). Obviously, only research institu-
tions in developed countries were able to adopt this technology.
Subsequently, several next-generation sequencing (NGS) technolo-
gies were introduced, providing a revolutionary means for extracting
the genetic information in massive amounts and within reasonable
costs. NGS enabled scientists to extend the genome sequencing applica-
tions to new dimensions and invent novel applications in several ﬁelds
(El-Metwally et al., 2014b). NGS is characterized by its high-throughput
nature that resulted in millions of short-read sequences that were-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
16 M. Helmy et al. / Applied & Translational Genomics 9 (2016) 15–19assembled to build the sequences of wholemolecules using sophisticat-
ed programs that required powerful computers (El-Metwally et al.,
2013). In spite of the remarkable increase in speed and decrease in
costs, establishing a genome sequencing facility with NGS technology
remains challenging, to the developed world, in part because the esti-
mated cost of establishing a facility ranges between $100 K to
$700 K U.S. dollars (El-Metwally et al., 2014a). Further, the costs are
greater when establishing NGS facility in developing world due to the
costs of shipments, customs and proﬁt margin for local companies.
This level of expense far exceeds the available funds for scientists in
most developing countries.
In this report, we employed the WB classiﬁcation and statistics, and
the Genome OnLine Database (GOLD) genome sequencing projects'
data to evaluate the utilization of genome sequencing technology in de-
veloping countries, and point out the challenges that confront the ﬁeld,
and proposed possible solutions.
2. Current state of sequencing technologies in developing countries
To evaluate the current status of the utilization of sequencing tech-
nologies in developing countries, we analyzed the genome sequencing
projects' data available through the Genome OnLine Database (GOLD)
(Reddy et al., 2015), aswell as theWB classiﬁcation of countries and sta-
tistics concerning worldwide expenditures for research and develop-
ment (R&D) (World Bank, 2015). The GOLD database is the world's
most comprehensive resource of information about the genome se-
quencing projects worldwide. As of November 2015, GOLD contained
information for about 63,325 genome projects, including the sequenc-
ing center(s) involved in each project, which allowedus tomap the pro-
jects to the countries. We excluded projects with missing information
(4935) or projects involve centers frommore than one country (despite
the classiﬁcation of the countries) (407). For the remaining projects
(57,983), we mapped the sequencing centers to the related countries
and obtained the number of centers and genome projects per country.
Subsequently, we associated this information with the country's R&D
expenditures.
Using this data, we calculated the average R&D expenditures of the
developing countries and classiﬁed them into two classes based on the
R&D spending. Developing countries with R&D expenditures greater
than twice the average (eight countries — see Fig. 1A) were put into a
separate class (Fig. 1A). The correlation between the genome sequenc-
ing projects and sequencing centers worldwide is illustrated in
Fig. 1B–C. Developed countries have more sequencing centers and
therefore, are able to sequence more genomes. Developing countries
with higher R&D spending, such as China, India and Brazil, are also im-
portant contributors to the ﬁeld (Fig. 1B–C). This analysis suggests that
genome sequencing technologies are underutilized in developing coun-
tries and that limited R&D funding is a major obstacle.
3. Challenges facing sequencing technologies in developing countries
Advancements in genome sequencing technologies resulted in re-
markable increases in accuracy and read-length, as well as decreases
in overall cost, which has spurred a signiﬁcant increase in the utilization
of these technologies and expanded the applications of these technolo-
gies beyond sequencing genomes to include genome resequencing, RNA
sequencing, exome sequencing and targeted sequencing in the devel-
oped world (Sims et al., 2014). However, these technologies are
underutilized in the majority of research laboratories and educational
institutions in the developingworld. This is mainly due to the following
factors.
3.1. The high cost of establishing and maintaining a sequencing facility
The signiﬁcant decrease in sequencing costs over the last decade
does not reﬂect in the prices of most of the sequencing instruments. Itwas estimated that the establishment of a NGS facility costs $100 K to
$700 K U.S. dollars for the sequencing instruments alone (Glenn,
2011). As indicated above, in the developing countries, this cost can in-
creasemore due to the addition of other costs such as shipment and cus-
toms. In addition, infrastructure and computational facilities are
required. Furthermore, the limited funding for the operational costs of
such facility (cost of reagents and instrument maintenance) is one of
the main factors that limit genome sequencing facilities in developing
countries. This is not affordable for most educational, research and clin-
ical laboratories in developing countries.
3.2. Lack of skilled personnel
Genome sequencing is an interdisciplinary ﬁeld that requires knowl-
edge in biology, chemistry and bioinformatics. The personnel working
in this ﬁeld require adequate training. Developing countries, however,
have limited capacities in education and human development (United
Nations, 2014). Insufﬁcient training, therefore, is a formidable obstacle
that limits the use of such facilities.
3.3. Limited access to tools for genomic data manipulation and analysis
The genomic data manipulation and analysis tools are an indispens-
able component of genomic research. Although several tools are distrib-
uted under different open source licenses, many advanced tools are
commercialized by companies or require complicated licensing proce-
dures to be used (El-Metwally et al., 2013). Such licensure fees are
frequently beyond the abilities of institutions in the developing world.
3.4. Weak or absence of a regulatory framework
The genome sequencing research and clinical applications can in-
volve sensitive information such as personal data (name, gender, date
of birth, race), medical history, and family history with diseases. Such
information should be handled carefully with restricted regulations to
protect the privacy and maintain the anonymity of the source of the
sample, as is the case for themost part in the developedworld. Howev-
er, the developing world genome sequencing research is rare or absent,
in addition to an overall weak infrastructure, weak or non-existent
regulatory frameworks (established legal and ethical conventions that
stipulate quality and proﬁciency standards, specimen shipment require-
ments and the like) can be viewed as limiting a country's capacity. The
scrutiny and rules set by the international research ethics communities
are not imposed and resources for enforcement are for the most part
non-existent (Conley et al., 2010).
3.5. Internet access limitations and limited access to up-to-date scientiﬁc
literature
Having access to up-to-date literature is crucial for working in
rapidly-evolving research ﬁelds. The recent growth of open access
publications has greatly assisted in making contemporary literature
available to scientists from developing countries. However, highly
respected journals that require subscription fees are unaffordable for
developing countries which means that important new knowledge is
inaccessible (Djikeng et al., 2012). In addition, genomic data download
and manipulation require fast and stable Internet connections that are
not always available in developing countries, especially in Africa
(Karikari et al., 2015; Slippers et al., 2011).
3.6. Low quality of outsourcing services
The lack of access to genome sequencing facilities in developing
countries makes outsourcing the only available option to utilize these
technologies. However, outsourcing companies provide low-quality
services in many developing countries. Typically, the companies do
Fig. 1. Current state of genome sequencing technologies worldwide. A) The distribution of developed and developing countries. The developing countries of high R&D spending are Brazil,
China, India, Kenya, Malaysia, Serbia, Tunisia and Turkey. B) Genome sequencing projects per country. C) Genome sequencing centers per country. The insert in B shows the correlation
between numbers of genome sequencing centers and the numbers of sequenced genomes per country. The analysis was performed based on data from GOLD andWorld Bank (see text).
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tives of companies in other countries. They send the samples to compa-
nies abroad to be sequenced and the results are sent back oncecompleted. The improper handling of the samples, transport, and long
service timing, all together are usually producing a low quality service.
Our personal experience and observations show that this is an
18 M. Helmy et al. / Applied & Translational Genomics 9 (2016) 15–19expensive and time-consuming process that may take up to several
months. Furthermore, the entire outsourcing process can fail at any
stage, which wastes more time and cost (Awad et al., 2015).
4. Potential solutions
Governments as well as academic and research institutes can take
several actions to overcome the challenges confronting the develop-
ment and utilization of this indispensable technology. We suggest po-
tential solutions that can be part of a larger plan for the sustainable
development of genome sequencing technologies in developing
countries.
4.1. Increase research funds for genomic research
By realizing the importance of genomic research and its applications
on health, drugs and food security, governmental policies should prior-
itize research funding for genomics. Our analysis of WB and GOLD data
demonstrates that the utilization of these technologies in developing
countries with sufﬁcient R&D spending is comparable to developed
countries (Fig. 1B–C). One clear example is the governmental fund by
the National Research Foundation in South Africa which has been allo-
cated for genomic research, hence boosting national development and
sustaining a leading position for South Africa in genomic research in
the continent (Karikari, 2015; Tastan Bishop et al., 2015).
4.2. Establishment of centralized sequencing facilities (centers of excellence)
Centers of excellence could be a very promising solution for provid-
ing high quality sequencing services for several laboratories and re-
search groups. These centers can be established at the national or
regional level. For example, the African Center of Excellence for Geno-
mics of Infectious Diseases (ACEGID) at Redeemer's University
(Nigeria) has been established by the support of the WB and NIH to
serve several institutions in the surrounding region, including Senegal,
Nigeria, and Sierra Leone (Folarin et al., 2014).
4.3. Fostering international collaborations
Collaboration between developed and developing countries in geno-
mic researchwill undoubtedly result in a substantial increase in scientif-
ic capacity. Several initiatives have been set up to support such
collaborations (Kumar, 2012). A recent example is the public health col-
laboration by TheGenomeScience Programat the LANational Laborato-
ry, USA and research institutions in several developing countries
including Jordan, Uganda, and Gabon (Cui et al., 2015). The developed
countries can also provide support for establishing the centers of excel-
lence (see above) by providing funding, equipment and training.
4.4. Create effective training programs
Developing the researchers' skills is one of the most important as-
pects in advancing genome research in developing countries. This de-
velopment should be in both experimental and computational skills.
Education and training in the basics of genomics and bioinformatics
may begin at the level of secondary schools. More advanced training
can be at the undergraduate and graduate levels (Karikari et al., 2015;
Tastan Bishop et al., 2015).
4.5. Provide means of accessing up-to-date genomic data and publications
Several scientiﬁc publishers have adopted the open access publica-
tion model for all their journals including PLOS, Frontiers, and BMC,
while other high-proﬁle publishers provide open access in some of
their journals such as Nature Communications and Science Advances.
The World Health Organization (WHO) and the Food and AgricultureOrganization (FAO) have also provided two initiatives for allowing ac-
cess to scientiﬁc literature in developing countries: HINARI (http://
www.who.int/hinari/en/) and AGORA (http://www.aginternetwork.
org/en/) (Djikeng et al., 2012). Despite these efforts, additional strate-
gies are required to effectively tackle the gap in access to new knowl-
edge. Creating central academic libraries that have access to non-open
access journals, and establishing agreements between the universities
and research centers in the developing countries and scientiﬁc pub-
lishers to grant access to scientiﬁc articles for free would ﬁll this gap.
4.6. Utilize modern sequencing technologies that minimize the
infrastructure requirements
Modern genome sequencing technologies, such as MinION by
Oxford Nanopore Technologies, have minimized the requirements of
adopting this technology to an affordable device, preparation kit, stable
Internet connection and standard PC. Although the technology is still
new and developing, it nonetheless represents a promising solution
for utilizing a wide range of genome sequencing applications and with
minimal laboratory and computational skills.
4.7. Developing alternative experimental methods
Occasionally, alternative experimental methods could be the best
choice in some cases where sequencing facilities are not available. In
our recent work, we have proposed an alternative restriction enzyme-
based method for bacterial identiﬁcation using standard microbiology
techniques (Awad et al., 2015). Developing such alternative experimen-
tal methods is more fruitful when combined with other computational
methods.
5. Conclusion
Several challenges confronting researchers and scientists in devel-
oping countries have delayed their ability to participate in the genomic
revolution. While, many developing countries including India, South
Africa, Mexico, and Brazil were able to make signiﬁcant strides in utiliz-
ing genomic technologies through the availability of sufﬁcient funds, es-
tablishing institutions for genomics, and the training of personnel, the
situation remains unaltered in several regions of the world, especially
Africa. We recommend increasing research funding, establishing cen-
ters of excellences, encouraging international collaborations and orga-
nizing specialized training programs as possible potential solutions for
the sustainable future improvement of genomic research in developing
countries.
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